Simplex Trading
CAI

Simplex Trading’s Caris Life Sciences CAI Stock Holding History

Simplex Trading’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
13,409
+10,740
+402% +$192K ﹤0.01% 4491
2026
Q1 		$47.7K Sell
2,669
-1,930
-42% -$42.2K ﹤0.01% 5933
2025
Q4 		$124K Buy
4,599
+616
+15% +$17.3K ﹤0.01% 4759
2025
Q3 		$120K Buy
3,983
+3,151
+379% +$100K ﹤0.01% 5534
2025
Q2 		$22K Buy
+832
New +$22.4K ﹤0.01% 6719

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Simplex Trading's CAI Position: Q2 2026 in Review

Simplex Trading increased its Caris Life Sciences (CAI) stake by 402% in Q2 2026, buying an estimated $192K and bringing the position to 13,409 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #4491.

Simplex Trading first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Simplex Trading held 13,409 shares of Caris Life Sciences worth $239K as of Q2 2026.
  • Simplex Trading bought 10,740 Caris Life Sciences shares in Q2 2026, an estimated $192K.
  • Caris Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4491 holding.
  • Simplex Trading first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.